Impact on the Use of Antibiotics of a Multimodal Algorithm for the Diagnosis and Management of Acute Community-acquired Pneumonia in the Emergency Room
Key facts
- Who runs it
- Assistance Publique - Hôpitaux de Paris
- Where
- France2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 295 people enrolled
- Started
- 9 Jan 2023
- Ended
- 11 Jun 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- CRP dosage
- multiplex PCR
- chest scan without injection
- Record updated
- 16 October 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Patient 18 years or older
- Presence of at least one respiratory sign among the following: dyspnea, cough, expectoration, auscultatory abnormalities, chest pain
- Presence of at least one general sign among the following: fever (T>38°C), hypothermia (T<35°C), myalgia, headache, asthenia
- Oxygen-requiring patient defined by a saturation <95% or presenting a risk area among:; Age > 65 years old; Alcoholic and/or tobacco intoxication; Congestive heart failure; Cerebrovascular disease (stroke or transient ischemic attack); Chronic kidney disease (excluding dialysis); Chronic liver disease; Unbalanced diabetes mellitus; Progressive neoplastic disease; Immunodepression (systemic corticosteroid therapy or immunosuppressive treatment within 6 months, splenectomy, chemotherapy within 6 months, HIV at the AIDS stage, cachexia, etc.); Homozygous sickle cell disease; Bacterial pneumonia; Hospitalization during the year; Institutional life; Non-inclusion Criteria:
- Patient unable to consent: coma or acute respiratory distress requiring orotracheal intubation
- Patient with chronic renal failure on dialysis
- Patient with a history of chronic obstructive pulmonary disease
- Lung transplant patient
- Patient being treated with antibiotics at the time of the emergency room consultation
- Patient simultaneously participating in an interventional study protocol (assessing the duration of antibiotic therapy)
- Pregnant or breastfeeding woman
- Patient refusal to participate
- Patient deprived of freedom or under a legal protective measure
- Patient under guardianship or curatorship or with cognitive impairment
- Non-affiliation to a social security regimen or CMU
Who cannot take part
- RT-PCR positive for SARS-CoV-2
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Reducing antibiotics prescription is still to date, the main goal in low respiratory tract infections (LRTI).
Read full original descriptionShow less
Several studies have shown conflicting results on the impact of multiplex PCR as a point of care tool. Our experience has highlighted an impact on single room assignments during the winter season but not yet on antibiotics prescriptions. This project aims to evaluate a new multimodal algorithm including multiplex PCR at the point of care to reduce antibiotics prescription and therefore has the ability to have a positive impact on antibiotics resistance phenomenon.
The 2 groups in the trial
- Intervention periodTreatment being tested
Patient management will be guided by a multimodal algorithm integrating the performance of biological and iconographic examinations
Treatment: CRP dosage, multiplex PCR, and chest scan without injection
- Control periodNo study treatment, for comparison
Patient management will be done according to the usual practices of centers and emergency physicians
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 16 October 2024